We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA Spells Out Structured Product Labeling for REMS
FDA Spells Out Structured Product Labeling for REMS
The FDA recommends drugmakers implementing the structured product labeling format for risk evaluation and mitigation strategies start by assembling its experts in both areas.